Phototherapy Market Research Report—Forecast till 2027

$4,450$6,250

According to Market Research Future analysis, the Global Phototherapy Market is anticipated to exhibit a 4.61% CAGR during the review period. As per the GBP analysis, skin disease is likely to be the leading cause of non-fatal disease burden worldwide.

Clear

Description

Phototherapy Market Research Report—Forecast till 2027

Market Snapshot
According to Market Research Future analysis, the Global Phototherapy Market is anticipated to exhibit a 4.61% CAGR during the review period. As per the GBP analysis, skin disease is likely to be the leading cause of non-fatal disease burden worldwide. Skin diseases are more common in men than in women and increases with the age. The monetary weight of psoriasis is around USD 35 billion in the US each year, and treatment costs are ascending than general swelling. Light-radiating diode (LED) phototherapy addresses a practical, protected, solid, and compact psoriasis therapy. Also, it has benefits, including low force utilization, low warmth creation, and a longer life expectancy of the light-radiating unit when contrasted with other light sources.
Global Phototherapy Market is expected to witness a notable market expansion during the study period owing to the rising occurrence of severe skin diseases and the increasing number of preterm and low-weight births. Additionally, the increasing adoption of LED-based phototherapy equipment is also fuelling the growth of the market during the review period. However, the major restraining factor for the growth of the global market is differential awareness and availability between countries and issues in venture capital, start-ups, and collaborations during the forecast period.

Market Segmentation
The global phototherapy market has been classified into product, radiation, application, end-user, and region.
Based on product type, the global market has been segmented into conventional phototherapy equipment, LED phototherapy equipment, fiberoptic phototherapy equipment, germicidal lamps, and accessories. Based on the radiation segment, the global market has been divided into UVA, UVB, and UVC. Based on application type, the global phototherapy market has been segregated into skin disease treatment, neonatal jaundice management, and sterilization. In terms of the end-user segment, the global phototherapy market has been classified into hospital & clinic, dermatology center, and homecare.

Regional Analysis
Geographically, the phototherapy market has been classified into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
Americas is likely to drive the largest phototherapy market is expected to register a 4.63% CAGR during the forecast period owing to the highest market share of 42.60% in 2019. The regional market growth is attributed to the surging demand for skin treatments in the US and Canada. Furthermore, the growing adoption of home phototherapy is fuelling the regional market growth during the review period. Home phototherapy is more patient-friendly in terms of avoiding frequent hospital visits and it is the most cost-effective treatment option for patients with moderate-to-severe psoriasis. Therefore, the phototherapy market in the Americas is likely to exhibit a 4.63% CAGR during the assessment period.
Europe is expected to contribute the second-largest market for the global phototherapy market followed by Asia-Pacific during the review period.
Major Players
The Prominent Players in the report on the Global Phototherapy Market include Signify Holding (Netherlands), Atom Medical Corporation (Japan), National Biological Corporation (US), Solarc Systems Inc. (Canada), GE Healthcare (US), Natus Medical Incorporated (US), Herbert Waldmann GmbH & Co. KG (Germany), Phoenix Medical Systems (P) Ltd (India), The Daavlin Company (US), and Strata Skin Sciences, Inc. (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW

1.2 MARKET ATTRACTIVENESS ANALYSIS

1.2.1 GLOBAL PHOTOTHERAPY MARKET, BY PRODUCT

1.2.1.1 GLOBAL PHOTOTHERAPY MARKET, BY CONVENTIONAL PHOTOTHERAPY EQUIPMENT

1.2.3 GLOBAL PHOTOTHERAPY MARKET, BY RADIATION

1.2.4 GLOBAL PHOTOTHERAPY MARKET, BY APPLICATION

1.2.4.1 GLOBAL PHOTOTHERAPY MARKET, BY SKIN DISEASE TREATMENT

1.2.4.2 GLOBAL PHOTOTHERAPY MARKET, BY STERILIZATION

1.2.5 GLOBAL PHOTOTHERAPY MARKET, BY END USER

1.2.6 GLOBAL PHOTOTHERAPY MARKET, BY REGION

2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS

3.2 PRIMARY RESEARCH

3.3 SECONDARY RESEARCH

3.4 MARKET SIZE ESTIMATION

3.5 FORECAST MODEL

3.6 LIST OF ASSUMPTIONS & LIMITATIONS

4 MARKET DYNAMICS
4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF SEVERE SKIN DISEASES

4.2.2 RISING NUMBER OF PRETERM AND LOW-WEIGHT BIRTHS

4.2.3 RISING ADOPTION OF LED-BASED PHOTOTHERAPY EQUIPMENT

4.2.4 DRIVERS IMPACT ANALYSIS

4.3 RESTRAINTS

4.3.1 DIFFERENTIAL AWARENESS AND AVAILABILITY BETWEEN COUNTRIES

4.3.2 ISSUES IN VENTURE CAPITAL, STARTUPS, AND COLLABORATIONS

4.3.3 RESTRAINTS IMPACT ANALYSIS

4.4 OPPORTUNITIES

4.4.1 RISING ADOPTION OF HOME PHOTOTHERAPY FOR THE TREATMENT OF SKIN DISEASES

5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 BARGAINING POWER OF BUYERS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL PHOTOTHERAPY MARKET

5.3.1 OVERVIEW

5.3.2 DEMAND-SUPPLY ANALYSIS

5.3.3 IMPACT ON PRODUCTION

6 GLOBAL PHOTOTHERAPY MARKET, BY PRODUCT
6.1 INTRODUCTION

6.2 CONVENTIONAL PHOTOTHERAPY EQUIPMENT

6.2.1 CONVENTIONAL PHOTOTHERAPY EQUIPMENT WITH FLUORESCENT LAMP

6.2.2 CONVENTIONAL PHOTOTHERAPY EQUIPMENT WITH COMPACT FLUORESCENT LAMPS

6.2.2.1 FULL-BODY PHOTOTHERAPY EQUIPMENT

6.2.2.2 PARTIAL-BODY PHOTOTHERAPY EQUIPMENT

6.3 LED PHOTOTHERAPY EQUIPMENT

6.4 FIBEROPTIC PHOTOTHERAPY EQUIPMENT

6.5 GERMICIDAL LAMPS

6.6 ACCESSORIES

7 GLOBAL PHOTOTHERAPY MARKET BY RADIATION
7.1 OVERVIEW

7.2 UVA

7.3 UVB

7.4 UVC

8 GLOBAL PHOTOTHERAPY MARKET, BY APPLICATION
8.1 OVERVIEW

8.2 SKIN DISEASE TREATMENT

8.2.1 PSORIASIS

8.2.2 VITILIGO

8.2.3 ECZEMA

8.2.4 OTHERS

8.3 NEONATAL JAUNDICE MANAGEMENT

8.4 STERILIZATION

8.4.1 HOSPITAL SERVICES

8.4.2 EQUIPMENT

9 GLOBAL PHOTOTHERAPY MARKET BY END USER
9.1 OVERVIEW

9.2 HOSPITAL & CLINIC

9.3 DERMATOLOGY CENTER

9.4 HOMECARE

9.5 LIST OF HOSPITALS AND CLINICS IN THE US

10 GLOBAL PHOTOTHERAPY MARKET, BY REGION
10.1 INTRODUCTION

10.2 AMERICAS

10.2.1 NORTH AMERICA

10.2.1.1 US

10.2.1.2 CANADA

10.2.2 LATIN AMERICA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 UK

10.3.1.4 ITALY

10.3.1.5 SPAIN

10.3.1.6 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST

10.5.2 ISRAEL

10.5.3 AFRICA

11 COMPETITIVE LANDSCAPE
11.1 COMPETITIVE OVERVIEW

11.2 COMPETITOR DASHBOARD

11.3 MARKET SHARE ANALYSIS

11.4 MAJOR GROWTH STRATEGIES IN THE GLOBAL PHOTOTHERAPY MARKET

11.5 COMPETITIVE BENCHMARKING

11.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL PHOTOTHERAPY MARKET

11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.7.1 CONTRACTS & AGREEMENTS

11.7.2 NEW PRODUCT DEVELOPMENTS/LAUNCHES

11.7.3 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES

11.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO

11.8.1 SALES & OPERATING INCOME

11.8.2 R&D EXPENDITURE

11.8.3 CURRENT CAPITAL MARKET RATIO

12 COMPANY PROFILES
12.1 SIGNIFY HOLDING

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS/SERVICES OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 GE HEALTHCARE

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS/SERVICES OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 NATUS MEDICAL INCORPORATED

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 HERBERT WALDMANN GMBH & CO. KG

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS/SERVICES OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 PHOENIX MEDICAL SYSTEMS (P) LTD

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 ATOM MEDICAL CORPORATION

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS/SERVICES OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 KEY STRATEGIES

12.7 NATIONAL BIOLOGICAL CORPORATION

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS/SERVICES OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 SOLARC SYSTEMS INC.

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS/SERVICES OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 THE DAAVLIN COMPANY

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 STRATA SKIN SCIENCES, INC.

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS/SERVICES OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 SWOT ANALYSIS

12.10.6 KEY STRATEGIES

13 APPENDIX
13.1 REFERENCES